7 Reasons Tryptophan and Serotonin Metabolism Change in Menopause (And What to Do)
The low mood and broken sleep hit at the same time, which makes sense once you understand they share the same root cause. What nobody mentioned was that the sadness and the 3am wakeups were connected through a single amino acid — and that something as ordinary as what you eat for dinner could actually move the needle.
Learn more about Rose →Estrogen Directly Upregulates the Enzyme That Makes Serotonin
Estrogen increases the activity of tryptophan hydroxylase, the rate-limiting enzyme responsible for converting tryptophan into 5-HTP and then into serotonin in the brain. When estrogen levels fall during perimenopause and menopause, that enzymatic activity drops alongside it, meaning the brain's capacity to synthesise serotonin is structurally reduced — not just temporarily disrupted. This is one of the clearest mechanistic links between hormonal change and the mood symptoms women report, and it explains why the shift can feel so sudden and so physical.
Estrogen Also Reduces the Breakdown of Serotonin
Beyond production, estrogen inhibits monoamine oxidase (MAO), the enzyme that degrades serotonin once it has been released. Higher estrogen means serotonin lingers longer in synapses; lower estrogen means MAO activity rises and serotonin is cleared faster, leaving less available to bind to receptors. This dual action — less production and faster breakdown — creates a compounding deficit that can have an outsized effect on mood, appetite regulation, and pain sensitivity all at once.
Tryptophan Is Increasingly Diverted Away from Serotonin Production
Tryptophan has more than one metabolic fate: it can become serotonin, but it can also be shunted down the kynurenine pathway, which produces compounds involved in immune regulation and, at high flux, some neuroactive metabolites that can worsen mood. Inflammation — which tends to rise in menopause due to the loss of estrogen's anti-inflammatory effects — activates the enzyme IDO (indoleamine 2,3-dioxygenase), pulling tryptophan toward kynurenine and away from serotonin synthesis. The result is that even with an adequate dietary intake of tryptophan, less of it may actually reach the serotonin pathway.
Lower Serotonin Disrupts Melatonin Production and Sleep Architecture
Serotonin is the direct precursor to melatonin, synthesised in the pineal gland during darkness, so a reduction in serotonin availability has a downstream knock-on effect on melatonin output. This helps explain why sleep fragmentation in menopause isn't just about hot flushes waking women up — the underlying circadian chemistry is altered too, making it harder to fall asleep, stay asleep, and reach restorative deep sleep stages. Women often describe waking at 3–4am feeling wired, which fits the pattern of blunted melatonin peaks and disrupted sleep pressure.
Dietary Tryptophan Can Support the Pathway — With Important Caveats
Foods rich in tryptophan — turkey, eggs, dairy, pumpkin seeds, tofu, oats — do contribute to the serotonin pathway, but dietary tryptophan competes with several other large neutral amino acids (like leucine and valine) for the same blood-brain barrier transporter. Eating tryptophan-rich foods alongside a moderate carbohydrate source, rather than with high-protein meals, is thought to increase the ratio of tryptophan crossing into the brain, because insulin reduces competing amino acids in the bloodstream. The evidence for this dietary strategy is real but modest in effect size — it supports the system rather than rescuing it.
5-HTP Bypasses the Rate-Limiting Step and Has Reasonable Evidence for Mood
5-HTP (5-hydroxytryptophan) is the intermediate between tryptophan and serotonin, and unlike tryptophan it crosses the blood-brain barrier efficiently without competing for transport. Several small randomised trials have found 5-HTP at doses of 50–300mg daily to be superior to placebo for depressive symptoms and to improve sleep onset latency, though studies specifically in menopausal women are limited. One genuine caution: 5-HTP should not be combined with SSRIs, SNRIs, tramadol, or other serotonergic medications without medical oversight, as the risk of serotonin syndrome — though rare — is real.
Hormone Therapy Remains the Most Effective Way to Restore This Pathway
Because the root disruption is estrogen withdrawal, restoring estrogen through hormone therapy (HT) addresses the serotonin deficit at its source — by upregulating tryptophan hydroxylase, suppressing MAO activity, and reducing the inflammatory signalling that diverts tryptophan down the kynurenine pathway. Multiple RCTs have shown that estrogen therapy improves mood symptoms in perimenopausal women, with effect sizes that compare favourably to antidepressants in this population, particularly for low mood that is clearly tied to hormonal fluctuation rather than a primary depressive disorder. Dietary and supplemental approaches are worth trying and can meaningfully support the pathway, but they work best as complements to rather than replacements for a conversation about HT with a knowledgeable clinician.
Want to go deeper?
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.